MAIN PRODUCTS INC is recalling approximately 57,340 bottles of Umary Acido Hialuronico (Hyaluronic Acid) 850 mg caplets because FDA testing found the product contains undeclared pharmaceutical ingredients. The product, which is marketed as a dietary supplement in 30-count bottles, was found to be tainted with diclofenac and omeprazole. All lots of this product that are currently within their expiration date are included in this recall.
The undeclared diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that can increase the risk of heart attack, stroke, and serious gastrointestinal damage, especially when taken with other medications. The undeclared omeprazole is a proton pump inhibitor that can cause significant drug interactions and may mask serious underlying stomach conditions.
You have 2 options:
Marketed as a dietary supplement; FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

“Umary Acido Hialuronico, Suplemento Alimenticio, 30 Capletas, front label”

“Nutrion information, back label”

“Suggested Use information, www.main-products.com, back label”

“Umary USA Hyaluronic Acid Dietary Supplement, 30 capsules”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.